The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of Calif ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report)’s share price hit a new 52-week low on Tuesday after Bank of America lowered their price target on the stock from $9.00 to $8.00.

NEW YORK CITY, NY / ACCESS Newswire / March 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 1,002 put options on the stock. This represents an ...

In this article, we are going to take a look at where Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) stands against the ...

Case No. 25-cv-00499, on behalf of persons and entities that purchased or otherwise acquired Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) securities ...

The Allegations: Rosen Law Firm is Investigating the Allegations that Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) Misled Investors Regarding its Business Operations.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney ...

MRVI CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Maravai LifeSciences Holdings, Inc. The Law Offices of Frank R. Cruz announces that it has filed a ...

Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to ...

Fintel reports that on February 26, 2025, Baird downgraded their outlook for Maravai LifeSciences Holdings (NasdaqGS:MRVI) ...